Final 48-Week Results of the APPLY-PNH Trial: Long-Term Efficacy & Safety in Anti-C5-Treated Patients With PNH & Persistent Anemia Undergoing Factor B Inhibition With Oral Iptacopan Monotherapy | VuMedi

Find latest Bleeding/Clotting Disorder videos · 300+ videos

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

10 seconds

Playback speed

Insights from 2023 ASH Annual Meeting

Final 48-Week Results of the APPLY-PNH Trial: Long-Term Efficacy & Safety in Anti-C5-Treated Patients With PNH & Persistent Anemia Undergoing Factor B Inhibition With Oral Iptacopan Monotherapy

By Insights from 2023 ASH Annual Meeting FEATURING Carlos de Castro

By Insights from 2023 ASH Annual Meeting FEATURING Carlos de Castro

315 views

April 3, 2024

Comments 0

Login to view comments. Click here to Login